Transce3nd’s Adient ADNT Stock Holding History

Transce3nd’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10	Closed	-$195	–	175
2025 Q2	$195	Hold	10	–	–	﹤0.01%	1163
2025 Q1	$129	Sell	10 -12	-55%	-$193	﹤0.01%	1151
2024 Q4	$379	Buy	+22	New	+$440	﹤0.01%	1341

Other funds holding ADNT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HHAM

HITE Hedge Asset Management Braintree, Massachusetts $1.77B AUM 38.67% 1-Year Est. Return

Transce3nd's ADNT Position: Q3 2025 in Review

Transce3nd sold out of Adient (ADNT) in Q3 2025, closing a stake of 10 shares — an estimated $195 sold.

Transce3nd first reported a position in ADNT in Q4 2024 and held it in 3 quarters. The position peaked at $379 in Q4 2024. 287 funds tracked by Wall St. Rank hold ADNT as of Q3 2025.

Transce3nd reported no remaining Adient position as of Q3 2025 after selling out during the quarter.
Transce3nd sold 10 Adient shares in Q3 2025, an estimated $195.
Transce3nd first reported a position in Adient in Q4 2024 and held it in 3 quarters.
Transce3nd's Adient position peaked at $379 in Q4 2024.
287 funds tracked by Wall St. Rank held Adient as of Q3 2025.

Based on Transce3nd's 13F filing for Q3 2025, filed 12 Nov 2025.